Herpes Zoster Optic Neuritis: A Catastrophe of a Disease.
Autor: | Mohd Zaidan KN; Department of Ophthalmology, Hospital Sultan Abdul Aziz Shah, Universiti Putra Malaysia, Serdang, MYS., Mohammad Razali A; Department of Ophthalmology, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, MYS., Md Noh MSF; Department of Radiology, Hospital Sultan Abdul Aziz Shah, Universiti Putra Malaysia, Serdang, MYS.; Department of Radiology, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, MYS., Md Saleh R; Department of Ophthalmology, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, MYS., Mohd Isa M; Department of Ophthalmology, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, MYS. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cureus [Cureus] 2024 May 15; Vol. 16 (5), pp. e60387. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024). |
DOI: | 10.7759/cureus.60387 |
Abstrakt: | Isolated herpes zoster optic neuritis is a rare sequelae of herpes zoster ophthalmicus (HZO). It can occur in the acute phase of HZO, or as post-herpetic complications. We report a case of a young patient with poorly controlled diabetes who developed herpes zoster optic neuritis one month after the initial skin manifestation despite completing a two-week course of oral acyclovir 800 mg five times a day. He complained of a five-day history of sudden onset, painless left eye blurring of vision. His vision over the left eye was no light perception with the presence of a left relative afferent pupillary defect. Fundus examination of the left eye revealed a swollen optic disc. Magnetic resonance imaging showed minimal fat streakiness over the left orbit. He was treated with one week of intravenous methylprednisolone 1 g/day, followed by a tapering dose of oral prednisolone (1 mg/kg/day) together with oral acyclovir 800 mg five times a day for another week. His visual acuity remained poor with a slight improvement in vision to hand motion. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Mohd Zaidan et al.) |
Databáze: | MEDLINE |
Externí odkaz: |